GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (LIM:JNJ) » Definitions » Cyclically Adjusted FCF per Share

Johnson & Johnson (LIM:JNJ) Cyclically Adjusted FCF per Share : $8.14 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Johnson & Johnson's adjusted free cash flow per share for the three months ended in Mar. 2025 was $1.388. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $8.14 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted FCF Growth Rate was 3.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 5.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 6.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Johnson & Johnson was 18.20% per year. The lowest was 4.50% per year. And the median was 9.70% per year.

As of today (2025-05-21), Johnson & Johnson's current stock price is $156.00. Johnson & Johnson's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $8.14. Johnson & Johnson's Cyclically Adjusted Price-to-FCF of today is 19.16.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Johnson & Johnson was 27.31. The lowest was 17.69. And the median was 23.28.


Johnson & Johnson Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted FCF per Share Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.01 6.67 6.98 7.61 8.07

Johnson & Johnson Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.05 7.90 8.11 8.07 8.14

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted Price-to-FCF falls into.


;
;

Johnson & Johnson Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.388/134.9266*134.9266
=1.388

Current CPI (Mar. 2025) = 134.9266.

Johnson & Johnson Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 1.674 100.684 2.243
201509 1.906 100.392 2.562
201512 1.328 99.792 1.796
201603 0.553 100.470 0.743
201606 1.362 101.688 1.807
201609 1.660 101.861 2.199
201612 2.010 101.863 2.662
201703 0.854 102.862 1.120
201706 1.854 103.349 2.420
201709 2.000 104.136 2.591
201712 1.774 104.011 2.301
201803 1.079 105.290 1.383
201806 1.912 106.317 2.427
201809 1.999 106.507 2.532
201812 1.807 105.998 2.300
201903 1.070 107.251 1.346
201906 1.899 108.070 2.371
201909 2.540 108.329 3.164
201912 1.922 108.420 2.392
202003 1.023 108.902 1.267
202006 1.047 108.767 1.299
202009 2.864 109.815 3.519
202012 2.629 109.897 3.228
202103 1.271 111.754 1.535
202106 1.685 114.631 1.983
202109 2.820 115.734 3.288
202112 1.616 117.630 1.854
202203 1.265 121.301 1.407
202206 1.768 125.017 1.908
202209 2.004 125.227 2.159
202212 1.418 125.222 1.528
202303 0.919 127.348 0.974
202306 1.165 128.729 1.221
202309 2.558 129.860 2.658
202312 2.387 129.419 2.489
202403 1.173 131.776 1.201
202406 1.923 132.554 1.957
202409 2.353 133.029 2.387
202412 1.992 133.157 2.018
202503 1.388 134.927 1.388

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Johnson & Johnson  (LIM:JNJ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=156.00/8.14
=19.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Johnson & Johnson was 27.31. The lowest was 17.69. And the median was 23.28.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Johnson & Johnson Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Industry
Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.